Prostatype Genomics AB Financial Overview
Prostatype Genomics AB's market cap is currently €1.70M. The company's EPS TTM is €; its P/E ratio is ―; Prostatype Genomics AB is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.